When a Promise Runs Shallow, How Does Prevention Weather the Storm of Cuts?

In the long arc of the fight against HIV, preventive medicine arrived as a hopeful current — a gentle counterflow to the pressures of new infections. Pre‑exposure prophylaxis, commonly known as PrEP, offered a way to slow the tide, its promise whispered in clinics and community centers alike. Yet even before new obstacles emerged on the horizon, that current ran shallow, with uptake far below the levels needed to turn the promise into broad protection.

Experts spoke of this quietly at the recent Conference on Retroviruses and Opportunistic Infections, noting that PrEP coverage, while expanding in parts of the world, was still modest in many countries even before funding reductions took hold. In wealthier nations like the United States, the ratio of people on PrEP to new infections remained low, and in many lower‑income settings where HIV incidence is highest, PrEP access was limited.

Then came a shift in the landscape of global health financing. Funding cuts — especially to longstanding programmes such as the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) — disrupted prevention services at a time when uptake had yet to reach critical mass. These actions have coincided with substantial declines in PrEP use in several African countries: in some cases, the number of people receiving PrEP dropped by as much as 98 % compared with the period before the cuts.

Such stark declines have implications that extend beyond numbers on a chart. PrEP, when used consistently, can reduce the risk of acquiring HIV dramatically, yet its effectiveness at a population level depends on broad, sustained coverage. In settings where service delivery, community outreach, and supply networks have been interrupted, the ability of PrEP to blunt new infections weakens. Moreover, these programmatic challenges arrive amid broader disruptions to HIV testing, counselling, and support services, all of which work in concert to prevent new infections.

The picture varies from region to region. Some countries that had earlier made strides in PrEP delivery experienced deep reversals after funding interruptions, while others saw modest declines or stagnation. Even outside Africa, disruptions in preventive services have been reported, reflecting a wider recalibration of foreign aid and public‑health priorities that continues to echo through health systems.

Health agencies, including the World Health Organization and UNAIDS, have underscored the need for renewed investment in prevention tools alongside efforts to scale up newer options like long‑acting injectable PrEP. These tools hold promise for diminishing barriers to adherence, but without reliable funding and distribution channels, their impact cannot be fully realized.

Researchers and advocates suggest that without corrective action, the erosion of PrEP services may slow global progress toward targets set for reducing new HIV infections and ending AIDS as a public‑health threat by 2030. The situation highlights the fragility of gains made to date and the importance of sustained, predictable funding to maintain and expand preventive efforts.

In straightforward news terms, global PrEP uptake was already limited in many regions, and recent funding cuts have led to significant declines in the number of people on PrEP, particularly in some African countries. Public‑health leaders continue to call for renewed and sustained investments to support HIV prevention services worldwide.

AI Image Disclaimer Visuals are created with AI tools and are not real photographs.

Sources: AIDSmap World Health Organization UNAIDS Kaiser Family Foundation CIDRAP